RAPT Therapeutics, Inc.
RAPT
$0.906
-$0.0151-1.64%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -72.46% | 41.25% | -9.43% | -4.27% | -34.53% |
| Total Depreciation and Amortization | -11.15% | -8.62% | 13.38% | 5.02% | 28.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 22.54% | 37.28% | 96.17% | 54.43% | 37.28% |
| Change in Net Operating Assets | 3,926.46% | -170.23% | 6.84% | -126.30% | 65.98% |
| Cash from Operations | 62.39% | 19.48% | 2.27% | -45.60% | -21.47% |
| Capital Expenditure | 98.51% | 74.24% | 100.43% | 86.17% | -36.73% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -104.07% | -28.48% | -41.19% | -38.65% | 150.23% |
| Cash from Investing | -104.08% | -28.37% | -40.77% | -37.23% | 150.01% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 31,147.82% | -100.00% | -8.60% | 7,689.66% | -99.39% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 31,147.82% | -100.00% | -8.60% | 7,689.66% | -99.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,080.40% | -79.27% | -287.44% | -131.68% | -159.23% |